跳至主要内容
临床试验/CTRI/2021/12/038676
CTRI/2021/12/038676招募中未知

Impact of cardiomyopathy and autonomic dysfunction on the survival, development of AKI and refractory ascites in decompensated cirrhosis patients.

Post Graduate Institute of Medical Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Age above 18 years.
  • 2.Patients having confirmed diagnosis of decompensated cirrhosis, any etiology (CTP class B and C will be included)
  • 3.Patients have given informed and written consent for participation in the study.

排除标准

  • 1.Pre-existing or known chronic kidney disease (CKD), cardiovascular accident, coronary artery disease, chronic obstructive pulmonary disease
  • 2.Diagnosis of hepatocellular carcinoma or other malignancy.
  • 3.Acute on chronic liver failure (ACLF), AKI, Refractory Ascites
  • 4.Active infection
  • 5.Active bleeding within last 7 days
  • 6.Human immunodeficiency virus seropositivity
  • 7.Pregnancy and lactation
  • 8.Refusal to participate in study

研究者

发起方
Post Graduate Institute of Medical Education and Research

相似试验

Impact of cardiac and autonomic nervous system... | 临床试验